Abstract

The research of the last decade pointed to the importance of vitamin D not only in bone metabolic processes, but also in immunologic and anticarcinogenic processes. Thus, its common insufficiency is related to serious health consequences – e.g. increased mortality and morbidity caused by autoimmune and cancer diseases. The modification of the range of values of vitamin D serum concentration and revision of its nutritional and pharmacological recommendations are suggested nowadays. Moreover, the discovery of the vitamin D receptor (VDR) enables us to understand its influence on other organs. To date the new properties of vitamin D are elucidated in the literature showing its preventive effect and possible application in supportive treatment of many diseases.

References

• 1. Alpert P.T., Shaikh U.: The effects of vitamin D deficiency andinsufficiency on the endocrine and paracrine systems. Biol. Res.Nurs., 2007; 9: 117-129
  Google Scholar
• 2. Armas L.A., Dowell S., Akhter M., Duthuluru S., Huerter C., HollisB.W., Lund R., Heaney R.P.: Ultraviolet-B radiation increases serum25-hydroxyvitamin D levels: the effect of UVB dose and skin color.J. Am. Acad. Dermatol., 2007; 57: 588-593
  Google Scholar
• 3. Bonakdar Z.S., Jahanshahifar L., Jahanshahifar F., GholamrezaeiA.: Vitamin D deficiency and its association with disease activityin new cases of systemic lupus erythematosus. Lupus, 2011; 20:1155-1160
  Google Scholar
• 4. Brenner M., Linge C.P., Li W., Li W., Gulko P.S.: Increased synovialexpression of nuclear receptors correlates with arthritis protection:a possible novel genetically regulated homeostatic mechanism. ArthritisRheum., 2011; 63: 2918-2929
  Google Scholar
• 5. Buell J.S., Dawson-Hughes B.: Vitamin D and neurocognitive dysfunction:preventing “D”ecline? Mol. Aspects Med., 2008; 29: 415-422
  Google Scholar
• 6. Cannell J.J., Hollis B.W.: Use of vitamin D in clinical practice. Altern.Med. Rev., 2008; 13: 6-20
  Google Scholar
• 7. Cantorna M.T., Hayes C.E., DeLuca H.F.: 1,25-Dihydroxycholecalciferolinhibits the progression of arthritis in murine models ofhuman arthritis. J. Nutr., 1998; 128: 68-72
  Google Scholar
• 8. Chapuy M.C., Arlot M.E., Duboeuf F., Brun J., Crouzet B., ArnaudS., Delmas P.D., Meunier P.J.: Vitamin D3 and calcium to prevent hipfractures in elderly women. N. Engl. J. Med., 1992; 327: 1637-1642
  Google Scholar
• 9. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., Lipsky P.E.: Modulatoryeffects of 1,25-dihydroxy-vitamin D3 on human B cell differentiation.J. Immunol., 2007; 179: 1634-1647
  Google Scholar
• 10. Cheng J.B., Levine M.A., Bell N.H., Mangelsdorf D.J., Russell D.W.:Genetic evidence that the human CYP2R1 enzyme is a key vitaminD 25-hydroxylase. Proc. Natl. Acad. Sci. USA, 2004; 101: 7711-7715
  Google Scholar
• 11. Chiu K.C., Chu A., Go V.L. Saad M.F.: Hypovitaminosis D is associatedwith insulin resistance and β cell dysfunction. Am. J. Clin.Nutr., 2004; 79: 820-825
  Google Scholar
• 12. Chung M., Balk E.M., Brendel M., Ip S., Lau J., Lee J., LichtensteinA., Patel K., Raman G., Tatsioni A., Terasawa T., Trikalinos T.A.: VitaminD and calcium: a systematic review of health outcomes. Evidencereport/technology assessment 2009; 183: 1-420
  Google Scholar
• 13. Colin E.M., Asmawidjaja P.S., van Hamburg J.P., Mus A.M., vanDriel M., Hazes J.M., van Leeuwen J.P., Lubberts E.: 1,25-dihydroxyvitaminD3 modulates Th17 polarization and interleukin-22 expressionby memory T cells from patients with early rheumatoid arthritis.Arthritis Rheum., 2010; 62: 132-142
  Google Scholar
• 14. Craig S.M., Yu F., Curtis J.R., Alarcón G.S., Conn D.L., Jonas B.,Callahan L.F., Smith E.A., Moreland L.W., Bridges S.L.Jr, Mikuls T.R.:Vitamin D status and its associations with disease activity and severityin African Americans with recent-onset rheumatoid arthritis.J. Rheumatol., 2010; 37: 275-281
  Google Scholar
• 15. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., MeunierP.J., Vieth R.: Estimates of optimal vitamin D status. Osteoporos.Int., 2005; 16: 713-716
  Google Scholar
• 16. DeLuca H.F.: Overview of general physiologic features and functionsof vitamin D. Am. J. Clin. Nutr., 2004; 80: 1689S-1696S
  Google Scholar
• 17. DeLuca H.F., Cantorna M.: Vitamin D: its role and uses in immunology.FASEB J., 2001; 15: 2579-2585
  Google Scholar
• 18. Dietary Supplement Fact Sheet: Vitamin D Office of Dietary Supplements(ODS). National Institutes of Health (NIH). Retrieved 2013-04-11
  Google Scholar
• 19. Dusso A.S., Brown A.J., Slatopolsky E.: Vitamin D. Am. J. Physiol.Renal. Physiol., 2005; 289: F8-F28
  Google Scholar
• 20. Etgen T., Bickel H., Förstl H.: Metabolic and endocrine factorsin mild cognitive impairment. Ageing Res. Rev., 2010; 9: 280-288
  Google Scholar
• 21. European Food Safety Authority (EFSA) Panel on Dietetic Products,Nutrition and Allergies (NDA). Scientific opinion on the substantiationof health claims related to vitamin D and normal functionof the immune system and inflammatory response (ID 154, 159),maintenance of normal muscle function (ID 155) and maintenance ofnormal cardiovascular function (ID 159) pursuant to Article 13(1) ofRegulation (EC) No 1924/2006”. EFSA J., 2010; 8: 1468-1485
  Google Scholar
• 22. European Food Safety Authority (EFSA) Panel on Dietetic Products,Nutrition and Allergies (NDA). Scientific opinion on the substantiationof a health claim related to vitamin D and risk of falling pursuant toArticle 14 of Regulation (EC) No 1924/2006. EFSA J., 2011; 9: 2382-2400
  Google Scholar
• 23. Giovannucci E.: Vitamin D status and cancer incidence and mortality.Adv. Exp. Med. Biol., 2008; 624: 31-42
  Google Scholar
• 24. Glerup H., Mikkelsen K., Poulsen L., Hass E., Overbeck S., ThomsenJ., Charles P., Eriksen E.F.: Commonly recommended daily intakeof vitamin D is not sufficient if sunlight exposure is limited. J. Intern.Med., 2000; 247: 260-268
  Google Scholar
• 25. Gordon C.M., DePeter K.C., Feldman H.A., Grace E., Emans S.J.:Prevalence of vitamin D deficiency among healthy adolescents. Arch.Pediatr. Adolesc. Med., 2004; 158: 531-537
  Google Scholar
• 26. Grant W.B.: Does vitamin D reduce the risk of dementia? J. AlzheimersDis., 2009; 17: 151-159
  Google Scholar
• 27. Grant W.B.: An estimate of premature cancer mortality in theU.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer,2002; 94: 1867-1875
  Google Scholar
• 28. Hanchette C.L., Schwartz G.G.: Geographic patterns of prostatecancer mortality: evidence for a protective effect of ultraviolet radiation.Cancer, 1992; 70: 2861-2869
  Google Scholar
• 29. Hathcock J.N., Shao A., Vieth R., Heaney R.: Risk assessment forvitamin D. Am. J. Clin. Nutr., 2007; 85: 6-18
  Google Scholar
• 30. Haussler M.R., Jurutka P.W., Hsieh J.C., Thompson P.D., SelznickS.H., Haussler C.A., Whitfield G.K.: New understanding of the molecularmechanism of receptor-mediated genomic actions of thevitamin D hormone. Bone, 1995; 17: 33S-38S
  Google Scholar
• 31. Haussler M.R., Norman A.: Chromosomal receptor for a vitaminD metabolite. Proc. Natl. Acad. Sci. USA, 1969; 62: 155-162
  Google Scholar
• 32. Heaney R.P., Davies K., Chen T., Holick M.F., Barger-Lux M.J.:Human serum 25-hydroxycholecalciferol response to extended oraldosing with cholecalciferol. Am. J. Clin. Nutr., 2003; 77: 204-210
  Google Scholar
• 33. Holick E.A., Lu Z., Holick M.T., Chen T.C., Shepard J., Holick M.F.:Production of previtamin D3 by a mercury arc lamp and a hybridincandescent/mercury arc lamp. W: Holick M.F. (red.) Biologic effectsof light 2001: proceedings of a symposium. Boston: KluwerAcademic, 2002: 205-212
  Google Scholar
• 34. Holick M.: Vitamin D deficiency. N. Engl. J. Med., 2007; 357:266-281
  Google Scholar
• 35. Holick M.F.: Clinical efficacy of 1,25- dihydroxyvitamin D3 andits analogues in the treatment of psoriasis. Retinoids, 1998; 14: 12-17
  Google Scholar
• 36. Holick M.F.: High prevalence of vitamin D inadequacy and implicationsfor health. Mayo Clin. Proc., 2006; 81: 353-373
  Google Scholar
• 37. Holick M.F.: Resurrection of vitamin D deficiency and rickets. J.Clin. Invest., 2006; 116: 2062-2072
  Google Scholar
• 38. Holick M.F.: Sunlight and vitamin D for bone health and preventionof autoimmune diseases, cancers, and cardiovascular disease.Am. J. Clin. Nutr., 2004; 80: 1678S-1688S
  Google Scholar
• 39. Holick M.F., Garabedian M.: Vitamin D: photobiology, metabolism,mechanism of action, and clinical applications. W: Favus M.J.(red.) Primer on the metabolic bone diseases and disorders of mineralmetabolism. 6th ed. Washington, DC: American Society for Boneand Mineral Research, 2006: 129-137
  Google Scholar
• 40. Hollis B.W.: Assessment and interpretation of circulating 25-hydroxyvitaminD and 1,25-dihydroxyvitamin D in the clinical environment.Endocrinol. Metab. Clin. North Am., 2010; 39: 271-286
  Google Scholar
• 41. Hollis B.W.: Assessment of vitamin D nutritional and hormonalstatus: what to measure and how to do it. Calcif. Tissue Int.,1996; 58: 4-5
  Google Scholar
• 42. Hollis B.W.: Circulating 25-hydroxyvitamin D levels indicative ofvitamin D sufficiency: implications for establishing a new effective dietaryintake recommendation for vitamin D. J. Nutr., 2005; 135: 317–322
  Google Scholar
• 43. Hollis B.W., Wagner C.L.: Vitamin D requirements during lactation:high-dose maternal supplementation as therapy to preventhypovitaminosis D for both the mother and the nursing infant. Am.J. Clin. Nutr., 2004; 80 (Suppl. 6): 1752S-1758S
  Google Scholar
• 44. Hyppönen E., Läärä E., Reunanen A., Järvelin M.R., VirtanenS.M.: Intake of vitamin D and risk of type 1 diabetes: a birth-cohortstudy. Lancet, 2001; 358: 1500-1503
  Google Scholar
• 45. Institute of Medicine (US) Committee to Review Dietary ReferenceIntakes for Vitamin D and Calcium (2011). “8, Implications andSpecial Concerns”. W: Ross A.C., Taylor C.L., Yaktine A.L., Del ValleH.B., Dietary Reference Intakes for Calcium and Vitamin D. WashingtonDC: National Academies Press, US
  Google Scholar
• 46. Jones G.: Expanding role for vitamin D in chronic kidney disease:importance of blood 25-OH-D levels and extra-renal 1α-hydroxylase in the classical and nonclassical actions of 1α,25-dihydroxyvitaminD3. Semin. Dial., 2007; 20: 316-324
  Google Scholar
• 47. Juzeniene A., Moan J.: Beneficial effects of UV radiation otherthan via vitamin D production. Dermatoendocrinol., 2012; 4: 109-117
  Google Scholar
• 48. Kerr G.S., Sabahi I., Richards J.S., Caplan L., Cannon G.W., ReimoldA., Thiele G.M., Johnson D., Mikuls T.R.: Prevalence of vitaminD insufficiency/deficiency in rheumatoid arthritis and associationswith disease severity and activity. J. Rheumatol., 2011; 38: 53-59
  Google Scholar
• 49. Li Y.C.: Vitamin D regulation of the renin-angiotensin system.J. Cell. Biochem., 2003; 88: 327-331
  Google Scholar
• 50. Lips P.: Vitamin D deficiency and secondary hyperparathyroidismin the elderly: consequences for bone loss and fractures andtherapeutic implications. Endocr. Rev., 2001; 22: 477-501
  Google Scholar
• 51. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., OchoaM.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., BalsR., Steinmeyer A., Zügel U. i wsp.: Toll-like receptor triggering ofa vitamin D-mediated human antimicrobial response. Science, 2006;311: 1770-1773
  Google Scholar
• 52. Losel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C.,Rossol-Haseroth K., Wehling M.: Nongenomic steroid action: controversies,questions,and answers. Physiol. Rev., 2003; 83: 965-1016
  Google Scholar
• 53. Malabanan A., Veronikis I.E., Holick M.F.: Redefining vitamin Dinsufficiency. Lancet, 1998; 351: 805-806
  Google Scholar
• 54. Matsuoka L.Y., Wortsman J., Haddad J.G., Hollis B.W.: In vivothreshold for cutaneous synthesis of vitamin D3. J. Lab. Clin. Med.,1989; 114: 301-305
  Google Scholar
• 55. Mok C.C., Birmingham D.J., Leung H.W., Hebert L.A., Song H.,Rovin B.H.: Vitamin D levels in Chinese patients with systemic lupuserythematosus: relationship with disease activity, vascular risk factorsand atherosclerosis. Rheumatology, 2012; 51: 644-652
  Google Scholar
• 56. Morimoto S., Kumahara Y.: A patient with psoriasis cured by 1alpha-hydroxyvitamin D3. Med. J. Osaka Univ., 1985; 35: 51-54
  Google Scholar
• 57. Nagpal S., Na S., Rathnachalam R.: Noncalcemic actions of vitaminD receptor ligands. Endocr. Rev., 2005; 26: 662-687
  Google Scholar
• 58. Nemere I., Yoshimoto Y., Norman A.W.: Calcium transport in perfusedduodena from normal chicks: enhancement within fourteenminutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology,1984; 115: 1476-1483
  Google Scholar
• 59. Norman A.W.: From vitamin D to hormone: fundamentals of thevitamin D endocrine system essential for good health. Am. J. Clin.Nutr., 2008; 88: 491S-499S
  Google Scholar
• 60. Norman A.W.: Minireview: vitamin D receptor: new assignmentsfor an already busy receptor. Endocrinology, 2006; 147: 5542-5548
  Google Scholar
• 61. Pittas A.G., Dawson-Hughes B.: Vitamin D and diabetes. J. SteroidBiochem. Mol. Biol., 2010; 121: 425-429
  Google Scholar
• 62. Ritterhouse L.L., Crowe S.R., Niewold T.B., Kamen D.L., MacwanaS.R., Roberts V.C., Dedeke A.B., Harley J.B., Scofield R.H., GuthridgeJ.M., James J.A.: Vitamin D deficiency is associated with an increasedautoimmune response in healthy individuals and in patients withsystemic lupus erythematosus. Ann. Rheum. Dis., 2011; 70: 1569-1574
  Google Scholar
• 63. Ross A.C., Taylor C.L., Yaktine A.L., Del Valle H.B.: Dietary ReferenceIntakes for Calcium and Vitamin D. Washington DC: NationalAcademies Press. 2011
  Google Scholar
• 64. Rossini M., Maddali Bongi S., La Montagna G., Minisola G., MalavoltaN., Bernini L., Cacace E., Sinigaglia L., Di Munno O., Adami S.:Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. ArthritisRes. Ther., 2010; 12: R216-R223
  Google Scholar
• 65. Rostand S.G.: Ultraviolet light may contribute to geographic andracial blood pressure differences. Hypertension, 1997; 30: 150-156
  Google Scholar
• 66. Ruiz-Irastorza G., Egurbide M.V., Olivares N., Martinez-BerriotxoaA., Aguirre C.: Vitamin D deficiency in systemic lupus erythematosus:prevalence, predictors and clinical consequences. Rheumatology,2008; 47: 920-923
  Google Scholar
• 67. Ruiz-Irastorza G., Gordo S., Olivares N., Egurbide M.V., Aguirre C.:Changes in vitamin D levels in patients with systemic lupus erythematosus:Effects on fatigue, disease activity, and damage. ArthritisCare Res., 2010; 62: 1160-1165
  Google Scholar
• 68. Schuster I.: Cytochromes P450 are essential players in the vitaminD signaling system. Biochim. Biophys. Acta, 2011; 1814: 186-199
  Google Scholar
• 69. Stumpf W.E., Sar M., Reid F.A., Tanaka Y., DeLuca H.F.: Targetcells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney,skin, pituitary, and parathyroid. Science, 1979; 206: 1188-1190
  Google Scholar
• 70. Sung V., Feldman D.: 1,25-Dihydroxy-vitamin D3 decreases humanprostate cancer cell adhesion and migration. Mol. Cell. Endocrinol.,2000; 164: 133-143
  Google Scholar
• 71. Szeto F.L., Sun J., Kong J., Duan Y., Liao A., Madara J.L., Li Y.C.:Involvement of the vitamin D receptor in the regulation of NF-kappaBactivity in fibroblasts. J. Steroid Biochem. Mol. Biol., 2007; 103:563-566
  Google Scholar
• 72. Szodoray P., Tarr T., Bazso A., Poor G., Szegedi G., Kiss E.: Theimmunopathological role of vitamin D in patients with SLE: datafrom a single centre registry in Hungary. Scand. J. Rheumatol., 2011;40: 122-126
  Google Scholar
• 73. Tetlow L.C., Woolley D.E.: The effects of 1α,25-dihydroxyvitaminD3 on matrix metalloproteinase and prostaglandin E2 production bycells of the rheumatoid lesion. Arthritis Res., 1999; 1: 63-70
  Google Scholar
• 74. Trouvin A.P., Goëb V.: Receptor activator of nuclear factor-κBligand and osteoprotegerin: maintaining the balance to preventbone loss. Clin. Interv. Aging, 2010; 5: 345-354
  Google Scholar
• 75. Vieth R.: Why the optimal requirement for vitamin D3 is probablymuch higher than what is officially recommended for adults.J. Steroid Biochem. Mol. Biol., 2004; 89-90: 575-579
  Google Scholar
• 76. Wolf G.: The discovery of vitamin D: the contribution of AdolfWindaus. J. Nutr., 2004; 134: 1299-1302
  Google Scholar
• 77. Wu P.W., Rhew E.Y., Dyer A.R., Dunlop D.D., Langman C.B., PriceH., Sutton-Tyrrell K., McPherson D.D., Edmundowicz D., KondosG.T., Ramsey-Goldman R.: 25-hydroxyvitamin D and cardiovascularrisk factors in women with systemic lupus erythematosus. ArthritisRheum., Arthritis Care Res., 2009; 61: 1387-1395
  Google Scholar
• 78. Zhang A.B., Zheng S.S.: Strong additive effect of calcitriol andcyclosporine A on lymphocyte proliferation in vitro and rat liverallotransplantations in vivo. Chin. Med. J., 2006; 119; 2090-2095
  Google Scholar
• 79. Zittermann A.: Vitamin D and disease prevention with specialreference to cardiovascular disease. Prog. Biophys. Mol. Biol., 2006;92: 39-48
  Google Scholar
• 80. Zittermann A., Gummert J.F., Börgermann J.: Vitamin D deficiencyand mortality. Curr. Opin. Clin. Nutr. Metab. Care, 2009; 12: 634-639
  Google Scholar

Full text